Latest News about CVS
Recent news which mentions CVS
CVS Faces DOJ Lawsuit Alleging Violations Of Controlled Substances Act And False Claims Act Over Opioid Prescriptions
December 19, 2024
From Benzinga
Pharmacy Benefit Managers Played Key Role in Worsening Opioid Crisis, Drug Makers Paid Staggering Rebates To Middlemen: NYT
December 18, 2024
From Benzinga
What's Going On With CVS Health, UnitedHealth And Cigna Group Shares?
December 17, 2024
From Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
December 17, 2024
From Benzinga
Insurer Stocks Sink After Trump Vows to ‘Knock Out the Middleman’
December 16, 2024
From Wall Street Pit
CVS, Cigna, UnitedHealth Shares Slide As Trump Targets Drug 'Middleman'
December 16, 2024
From Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
December 16, 2024
From Benzinga
Is Walgreens Boots Alliance a Millionaire Maker?
December 15, 2024
From Motley Fool
Joe Rogan On Public Sympathy For UnitedHealthcare CEO Murder Suspect: Health Insurance A 'Dirty, Dirty Business'
December 12, 2024
From Benzinga
Stock Of The Day: Historic Technical Analysis Lesson In CVS
December 12, 2024
Tickers
CVS
From Benzinga
From Benzinga
Why UnitedHealth Group Stock Was Falling Today
December 11, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 11, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 10, 2024
From Benzinga
Blue Shield's $500 Million Drug Savings Initiative With Amazon Pharmacy Can Potentially Launch In January
December 06, 2024
From Benzinga
From Benzinga
From Benzinga
Is CVS Health Stock a Buy?
December 02, 2024
From Motley Fool
CVS Health's Options: A Look at What the Big Money is Thinking
November 29, 2024
Tickers
CVS
From Benzinga
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
November 28, 2024
From Benzinga
Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too?
November 25, 2024
From Motley Fool
Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge: Analyst Calls 2025 A 'Primetime' Year For AI
November 24, 2024
From Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
November 21, 2024
From Benzinga
Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex'
November 21, 2024
From Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.